There are two licensed Chikungunya vaccines.
IXCHIQ: A live attenuated vaccine suitable for immunocompetent individuals aged 18–59 years. The live vaccine (Ixchiq) has a protection of 98.9% at 28 days after vaccination.
Vimkunya: A virus-like particle vaccine using recombinant DNA technology available for individuals aged 12 years and older